发明授权
US07456315B2 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
有权
生物可利用的二酰肼配体,用于通过蜕皮激素受体复合物调节外源基因的表达
- 专利标题: Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
- 专利标题(中): 生物可利用的二酰肼配体,用于通过蜕皮激素受体复合物调节外源基因的表达
-
申请号: US10787906申请日: 2004-02-26
-
公开(公告)号: US07456315B2公开(公告)日: 2008-11-25
- 发明人: Robert Eugene Hormann , David W. Potter , Orestes Chortyk , Colin M. Tice , Glenn Richard Carlson , Andrew Meyer , Thomas R. Opie
- 申请人: Robert Eugene Hormann , David W. Potter , Orestes Chortyk , Colin M. Tice , Glenn Richard Carlson , Andrew Meyer , Thomas R. Opie
- 申请人地址: US VA Blacksburg
- 专利权人: Intrexon Corporation
- 当前专利权人: Intrexon Corporation
- 当前专利权人地址: US VA Blacksburg
- 代理机构: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- 主分类号: C07C243/38
- IPC分类号: C07C243/38 ; C07D213/63
摘要:
The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.
公开/授权文献
信息查询